<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34944061</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>16</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Differences of Transport Activity of Arginine and Regulation on Neuronal Nitric Oxide Synthase and Oxidative Stress in Amyotrophic Lateral Sclerosis Model Cell Lines.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3554</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells10123554</ELocationID><Abstract><AbstractText>L-Arginine, a semi-essential amino acid, was shown to delay dysfunction of motor neurons and to prolong the lifespan, upon analysis of transgenic mouse models of amyotrophic lateral sclerosis (ALS). We investigated the transport function of arginine and neuronal nitric oxide synthase (nNOS) expression after pretreatment with L-arginine in NSC-34 hSOD1<sup>WT</sup> (wild-type, WT) and hSOD1<sup>G93A</sup> (mutant-type, MT) cell lines. [<sup>3</sup>H]L-Arginine uptake was concentration-dependent, voltage-sensitive, and sodium-independent in both cell lines. Among the cationic amino acid transporters family, including system y+, b<sup>0,+</sup>, B<sup>0,+</sup>, and y<sup>+</sup>L, system y<sup>+</sup> is mainly involved in [<sup>3</sup>H]L-arginine transport in ALS cell lines. System b<sup>0,+</sup> accounted for 23% of the transport in both cell lines. System B<sup>0,+</sup> was found only in MT, and whereas, system y<sup>+</sup>L was found only in WT. Lysine competitively inhibited [<sup>3</sup>H]L-arginine uptake in both cell lines. The nNOS mRNA expression was significantly lower in MT than in WT. Pretreatment with arginine elevated nNOS mRNA levels in MT. Oxidizing stressor, H<sub>2</sub>O<sub>2</sub>, significantly decreased their uptake; however, pretreatment with arginine restored the transport activity in both cell lines. In conclusion, arginine transport is associated with system y<sup>+</sup>, and neuroprotection by L-arginine may provide an edge as a possible therapeutic target in the treatment of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Latif</LastName><ForeName>Sana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>College of Pharmacy and Drug Information Research Institute, Sookmyung Women's University, 100 Cheongpa-ro 47-gil, Yongsan-gu, Seoul 04310, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Young-Sook</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>College of Pharmacy and Drug Information Research Institute, Sookmyung Women's University, 100 Cheongpa-ro 47-gil, Yongsan-gu, Seoul 04310, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2019R1F1A1044048</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026923">Amino Acid Transport Systems, Basic</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="C496320">NOS1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="D052248">Nitric Oxide Synthase Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>K3Z4F929H6</RegistryNumber><NameOfSubstance UI="D008239">Lysine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D026923" MajorTopicYN="N">Amino Acid Transport Systems, Basic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008239" MajorTopicYN="N">Lysine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D052248" MajorTopicYN="N">Nitric Oxide Synthase Type I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">L-arginine</Keyword><Keyword MajorTopicYN="N">NSC-34 cell lines</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cationic amino acid transporter</Keyword><Keyword MajorTopicYN="N">nitric oxide synthase</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34944061</ArticleId><ArticleId IdType="pmc">PMC8700480</ArticleId><ArticleId IdType="doi">10.3390/cells10123554</ArticleId><ArticleId IdType="pii">cells10123554</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee J., Ryu H., Kowall N.W. Motor neuronal protection by l-arginine prolongs survival of mutant SOD1 (G93A) ALS mice. Biochem. Biophys. Res. Commun. 2009;384:524&#x2013;529. doi: 10.1016/j.bbrc.2009.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.05.015</ArticleId><ArticleId IdType="pmc">PMC2744197</ArticleId><ArticleId IdType="pubmed">19427829</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Oliveira T., Montezinho L., Mendes C., Firuzi O., Saso L., Oliveira P.J., Silva F.S.G. Oxidative Stress in amyotrophic lateral sclerosis. Oxid. Med. Cell. Longev. 2020;2020:5021694. doi: 10.1155/2020/5021694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/5021694</ArticleId><ArticleId IdType="pmc">PMC7683149</ArticleId><ArticleId IdType="pubmed">33274002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman J.M., Lyu Y., Pletcher S.D., Promislow D.E.L. Proteomics and metabolomics in ageing research: From biomarkers to systems biology. Essays Biochem. 2017;61:379&#x2013;388. doi: 10.1042/EBC20160083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20160083</ArticleId><ArticleId IdType="pmc">PMC5743054</ArticleId><ArticleId IdType="pubmed">28698311</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#x142;zecka J., Stelmasiak Z., Solski J., Wawrzycki S., Szpetnar M. Plasma amino acids concentration in amyotrophic lateral sclerosis patients. Amino Acids. 2003;25:69&#x2013;73. doi: 10.1007/s00726-002-0352-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-002-0352-2</ArticleId><ArticleId IdType="pubmed">12836061</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung M.-K., Kim K.Y., Lee N.-Y., Kang Y.-S., Hwang Y.J., Kim Y., Sung J.-J., McKee A., Kowall N., Lee J., et al. Expression of taurine transporter (TauT) is modulated by heat shock factor 1 (HSF1) in motor neurons of ALS. Mol. Neurobiol. 2013;47:699&#x2013;710. doi: 10.1007/s12035-012-8371-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-012-8371-9</ArticleId><ArticleId IdType="pmc">PMC8383465</ArticleId><ArticleId IdType="pubmed">23180277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N.Y., Kim Y., Ryu H., Kang Y.S. The alteration of serine transporter activity in a cell line model of amyotrophic lateral sclerosis (ALS) Biochem. Biophys. Res. Commun. 2017;483:135&#x2013;141. doi: 10.1016/j.bbrc.2016.12.178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.12.178</ArticleId><ArticleId IdType="pubmed">28043791</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali A., Kang Y.S. Pretreatment effect of inflammatory stimuli and characteristics of tryptophan transport on brain capillary endothelial (Tr-bbb) and motor neuron like (nsc-34) cell lines. Biomedicines. 2021;9:9. doi: 10.3390/biomedicines9010009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9010009</ArticleId><ArticleId IdType="pmc">PMC7823355</ArticleId><ArticleId IdType="pubmed">33374302</ArticleId></ArticleIdList></Reference><Reference><Citation>Luiking Y.C., Ten Have G.A.M., Wolfe R.R., Deutz N.E.P. Arginine de novo and nitric oxide production in disease states. Am. J. Physiol.-Endocrinol. Metab. 2012;303:E1177&#x2013;E1189. doi: 10.1152/ajpendo.00284.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00284.2012</ArticleId><ArticleId IdType="pmc">PMC3517635</ArticleId><ArticleId IdType="pubmed">23011059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo S., Mi J.D., Henderson R., McCombe P.A., Steyn F. Exploring targets and therapies for amyotrophic lateral sclerosis: Current insights into dietary interventions. Degener. Neurol. Neuromuscul. Dis. 2017;7:95&#x2013;108. doi: 10.2147/DNND.S120607.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DNND.S120607</ArticleId><ArticleId IdType="pmc">PMC6053104</ArticleId><ArticleId IdType="pubmed">30050381</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L., Schlagowski A., Ngo S.T., Vernay A., Dirrig-Grosch S., Henriques A., Boutillier A., Zoll J., Echaniz-Laguna A., Loeffler J., et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546. doi: 10.15252/emmm.201404433.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201404433</ArticleId><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ham D.J., Caldow M.K., Lynch G.S., Koopman R. Arginine protects muscle cells from wasting in vitro in an mTORC1-dependent and NO-independent manner. Amino Acids. 2014;46:2643&#x2013;2652. doi: 10.1007/s00726-014-1815-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-014-1815-y</ArticleId><ArticleId IdType="pubmed">25096520</ArticleId></ArticleIdList></Reference><Reference><Citation>Jungnickel K.E.J., Parker J.L., Newstead S. Structural basis for amino acid transport by the CAT family of SLC7 transporters. Nat. Commun. 2018;9:550. doi: 10.1038/s41467-018-03066-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03066-6</ArticleId><ArticleId IdType="pmc">PMC5803215</ArticleId><ArticleId IdType="pubmed">29416041</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomi M., Kitade N., Hirose S., Yokota N., Akanuma S.I., Tachikawa M., Hosoya K.I. Cationic amino acid transporter 1-mediated l-arginine transport at the inner blood-retinal barrier. J. Neurochem. 2009;111:716&#x2013;725. doi: 10.1111/j.1471-4159.2009.06367.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06367.x</ArticleId><ArticleId IdType="pubmed">19712052</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakoji N., Akanuma S.I., Tachikawa M., Hosoya K.I. Involvement of cationic amino acid transporter 1 in L-arginine transport in rat retinal pericytes. Biol. Pharm. Bull. 2015;38:257&#x2013;262. doi: 10.1248/bpb.b14-00637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b14-00637</ArticleId><ArticleId IdType="pubmed">25747984</ArticleId></ArticleIdList></Reference><Reference><Citation>Dev&#xe9;s R., Boyd C.A.R. Transporters for cationic amino acids in animal cells: Discovery, structure, and function. Physiol. Rev. 1998;78:487&#x2013;545. doi: 10.1152/physrev.1998.78.2.487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1998.78.2.487</ArticleId><ArticleId IdType="pubmed">9562037</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Kane R.L., Vi&#xf1;a J.R., Simpson I., Zaragoz&#xe1; R., Mokashi A., Hawkins R.A. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+ Am. J. Physiol.-Endocrinol. Metab. 2006;291:412&#x2013;419. doi: 10.1152/ajpendo.00007.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00007.2006</ArticleId><ArticleId IdType="pubmed">16569760</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahyaoui R., P&#xe9;rez-Fr&#xed;as J. Amino acid transport defects in human inherited metabolic disorders. Int. J. Mol. Sci. 2020;21:119. doi: 10.3390/ijms21010119.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21010119</ArticleId><ArticleId IdType="pmc">PMC6981491</ArticleId><ArticleId IdType="pubmed">31878022</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Winkle L.J., Iannaccone P.M., Campione A.L., Garton R.L. Transport of cationic and zwitterionic amino acids in preimplantation rat conceptuses. Dev. Biol. 1990;142:184&#x2013;193. doi: 10.1016/0012-1606(90)90162-C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0012-1606(90)90162-C</ArticleId><ArticleId IdType="pubmed">2227094</ArticleId></ArticleIdList></Reference><Reference><Citation>Palac&#xed;n M., Est&#xe9;vez R., Bertran J., Zorzano A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev. 1998;78:969&#x2013;1054. doi: 10.1152/physrev.1998.78.4.969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1998.78.4.969</ArticleId><ArticleId IdType="pubmed">9790568</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd C.A.R., Deves R., Laynes R., Kudo Y., Sebastio G. Cationic amino acid transport through system y+L in erythrocytes of patients with lysinuric protein intolerance. Pflugers Arch. Eur. J. Physiol. 2000;439:513&#x2013;516. doi: 10.1007/s004249900215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004249900215</ArticleId><ArticleId IdType="pubmed">10764208</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog. Neurobiol. 2001;64:365&#x2013;391. doi: 10.1016/S0301-0082(00)00056-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(00)00056-3</ArticleId><ArticleId IdType="pubmed">11275358</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Ryu H., Kowall N.W. Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice. Biochem. Biophys. Res. Commun. 2009;387:202&#x2013;206. doi: 10.1016/j.bbrc.2009.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.07.007</ArticleId><ArticleId IdType="pmc">PMC2742676</ArticleId><ArticleId IdType="pubmed">19580782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hyeon S.J., Im H., Ryu H., Kim Y., Ryu H. Astrocytes and Microglia as Non-cell Autonomous Players in the Pathogenesis of ALS. Exp. Neurobiol. 2016;25:233&#x2013;240. doi: 10.5607/en.2016.25.5.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y.Z., Yang S., Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 2002;18:872&#x2013;879. doi: 10.1016/S0899-9007(02)00916-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0899-9007(02)00916-4</ArticleId><ArticleId IdType="pubmed">12361782</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordberg J., Arn&#xe9;r E.S.J. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001;31:1287&#x2013;1312. doi: 10.1016/S0891-5849(01)00724-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(01)00724-9</ArticleId><ArticleId IdType="pubmed">11728801</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Feng Y., Zhang Y., Zhu X., Jin F. L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo. BMC Cancer. 2016;16:343. doi: 10.1186/s12885-016-2376-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-016-2376-0</ArticleId><ArticleId IdType="pmc">PMC4888479</ArticleId><ArticleId IdType="pubmed">27246354</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier O., B&#xf6;hm J., Dahm M., Br&#xfc;ck S., Beyer C., Johann S. Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration. Neurochem. Int. 2013;62:1029&#x2013;1038. doi: 10.1016/j.neuint.2013.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2013.03.008</ArticleId><ArticleId IdType="pubmed">23562846</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali A., Gautam S., Hyeon S.J., Ryu H., Kang Y.S. L-Citrulline level and transporter activity are altered in experimental models of amyotrophic lateral sclerosis. Mol. Neurobiol. 2021;58:647&#x2013;657. doi: 10.1007/s12035-020-02143-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02143-6</ArticleId><ArticleId IdType="pubmed">33000451</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.E., Kang Y.S. L-Citrulline restores nitric oxide level and cellular uptake at the brain capillary endothelial cell line (TR-BBB cells) with glutamate cytotoxicity. Microvasc. Res. 2018;120:29&#x2013;35. doi: 10.1016/j.mvr.2018.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2018.05.010</ArticleId><ArticleId IdType="pubmed">29870781</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S.Y., Xu Q., Hutchinson D., Colton C.A. Y+ and y+L arginine transporters in neuronal cells expressing tyrosine hydroxylase. Biochim. Biophys. Acta-Mol. Cell Res. 2005;1745:65&#x2013;73. doi: 10.1016/j.bbamcr.2004.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2004.12.006</ArticleId><ArticleId IdType="pubmed">16085056</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali A., Kang Y.S. Blood-to-Retina transport of imperatorin involves the carrier-mediated transporter system at the inner blood-retinal barrier. J. Pharm. Sci. 2019;108:1619&#x2013;1626. doi: 10.1016/j.xphs.2018.11.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xphs.2018.11.040</ArticleId><ArticleId IdType="pubmed">30528198</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyawali A., Kang Y.S. Transport alteration of 4-phenyl butyric acid mediated by a sodium- and proton-coupled monocarboxylic acid transporter system in ALS model cell lines (NSC-34) under inflammatory states. J. Pharm. Sci. 2021;110:1374&#x2013;1384. doi: 10.1016/j.xphs.2020.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xphs.2020.10.030</ArticleId><ArticleId IdType="pubmed">33098824</ArticleId></ArticleIdList></Reference><Reference><Citation>Shima Y., Maeda T., Aizawa S., Tsuboi I., Kobayashi D., Kato R., Tamai I. L-arginine import via cationic amino acid transporter CAT1 is essential for both differentiation and proliferation of erythrocytes. Blood. 2006;107:1352&#x2013;1356. doi: 10.1182/blood-2005-08-3166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-08-3166</ArticleId><ArticleId IdType="pubmed">16210335</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis K.E., Rasmussen A.L., Bennett W., King A., West A.K., Chung R.S., Chuah M.I. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: Changes in arginase1 and inducible nitric oxide synthase. J. Neuroinflammation. 2014;11:55. doi: 10.1186/1742-2094-11-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-11-55</ArticleId><ArticleId IdType="pmc">PMC3994340</ArticleId><ArticleId IdType="pubmed">24655927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C., Keller S., Altevogt P., Costa J. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci. Lett. 2007;428:43&#x2013;46. doi: 10.1016/j.neulet.2007.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.09.024</ArticleId><ArticleId IdType="pubmed">17942226</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergaard N., Beart P.M., Schousboe A. Transport of l-[3H]arginine in cultured neurons: Characteristics and inhibition by nitric oxide synthase inhibitors. J. Neurochem. 1993;61:364&#x2013;367. doi: 10.1111/j.1471-4159.1993.tb03579.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1993.tb03579.x</ArticleId><ArticleId IdType="pubmed">7685815</ArticleId></ArticleIdList></Reference><Reference><Citation>Verrey F., Closs E.I., Wagner C.A., Palacin M., Endou H., Kanai Y. CATs and HATs: The SLC7 family of amino acid transporters. Pflug. Arch. Eur. J. Physiol. 2004;447:532&#x2013;542. doi: 10.1007/s00424-003-1086-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-003-1086-z</ArticleId><ArticleId IdType="pubmed">14770310</ArticleId></ArticleIdList></Reference><Reference><Citation>Deves R., Angelo S., Rojas A. System y+L: The broad scope and cation modulated amino acid transporter. Exp. Physiol. 1998;83:211&#x2013;220. doi: 10.1113/expphysiol.1998.sp004105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.1998.sp004105</ArticleId><ArticleId IdType="pubmed">9568481</ArticleId></ArticleIdList></Reference><Reference><Citation>Latif S., Kang Y. Change in cationic amino acid transport system and effect of lysine pretreatment on inflammatory state in amyotrophic lateral sclerosis cell model. Biomol. Ther. 2021;29:498&#x2013;505. doi: 10.4062/biomolther.2021.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.4062/biomolther.2021.037</ArticleId><ArticleId IdType="pmc">PMC8411026</ArticleId><ArticleId IdType="pubmed">33935047</ArticleId></ArticleIdList></Reference><Reference><Citation>Arancibia-Garavilla Y., Toledo F., Casanello P., Sobrevia L. Nitric oxide synthesis requires activity of the cationic and neutral amino acid transport system y+L in human umbilical vein endothelium. Exp. Physiol. 2003;88:699&#x2013;710. doi: 10.1113/eph8802647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/eph8802647</ArticleId><ArticleId IdType="pubmed">14603368</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;rnquist P., Alm A. Carrier-mediated transport of amino acids through the blood-retinal and the blood-brain barriers. Graefe&#x2019;s Arch. Clin. Exp. Ophthalmol. 1986;224:21&#x2013;25. doi: 10.1007/BF02144127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02144127</ArticleId><ArticleId IdType="pubmed">3943730</ArticleId></ArticleIdList></Reference><Reference><Citation>Closs E.I., Boissel J.-P., Habermeier A., Rotmann A. Structure and function of cationic amino acid transporters (CATs) J. Membr. Biol. 2006;213:67&#x2013;77. doi: 10.1007/s00232-006-0875-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00232-006-0875-7</ArticleId><ArticleId IdType="pubmed">17417706</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L.P.H., Deeks E.D. Dextromethorphan/Quinidine: A Review of Its Use in Adults with Pseudobulbar Affect. Drugs. 2015;75:83&#x2013;90. doi: 10.1007/s40265-014-0328-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-014-0328-z</ArticleId><ArticleId IdType="pubmed">25420446</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Chen S., Lu K., Wang F., Deng J., Xu Z., Wang X., Zhou Q., Le W., Zhao Y. Verapamil ameliorates motor neuron degeneration and improves lifespan in the SOD1G93A mouse model of als by enhancing autophagic flux. Aging Dis. 2019;10:1159&#x2013;1173. doi: 10.14336/AD.2019.0228.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2019.0228</ArticleId><ArticleId IdType="pmc">PMC6844595</ArticleId><ArticleId IdType="pubmed">31788329</ArticleId></ArticleIdList></Reference><Reference><Citation>Su T.-Z., Lunney E., Campbell G., Oxender D.L. Transport of gabapentin, a &#x3b3;-amino acid drug, by system L &#x3b1;-amino acid transporters: A comparative study in astrocytes, synaptosomes, and CHO cells. J. Neurochem. 1995;64:2125&#x2013;2131. doi: 10.1046/j.1471-4159.1995.64052125.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1995.64052125.x</ArticleId><ArticleId IdType="pubmed">7722496</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Shimohama S. The role of nitric oxide in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2001;2:71&#x2013;81. doi: 10.1080/146608201316949415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608201316949415</ArticleId><ArticleId IdType="pubmed">11675875</ArticleId></ArticleIdList></Reference><Reference><Citation>Wileman S.M., Mann G.E., Pearson J.D., Baydoun A.R. Role of L-citrulline transport in nitric oxide synthesis in rat aortic smooth muscle cells activated with LPS and interferon-&#x3b3;. Br. J. Pharmacol. 2003;140:179&#x2013;185. doi: 10.1038/sj.bjp.0705407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0705407</ArticleId><ArticleId IdType="pmc">PMC1574005</ArticleId><ArticleId IdType="pubmed">12967947</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen I., Singhrao S.K., Potempa J. Citrullination as a plausible link to periodontitis, rheumatoid arthritis, atherosclerosis and Alzheimer&#x2019;s disease. J. Oral Microbiol. 2018;10:1487742. doi: 10.1080/20002297.2018.1487742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20002297.2018.1487742</ArticleId><ArticleId IdType="pmc">PMC6022223</ArticleId><ArticleId IdType="pubmed">29963294</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xf9; G., Vergani L., Fedrizzi L., D&#x2019;Ascenzo C., Polo A., Bernazzi B., Angelini C. Activities of mitochondrial complexes correlate with nNOS amount in muscle from ALS patients. Neuropathol. Appl. Neurobiol. 2007;33:204&#x2013;211. doi: 10.1111/j.1365-2990.2006.00791.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.2006.00791.x</ArticleId><ArticleId IdType="pubmed">17359361</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>